Back
Mereo BioPharma Group PLC 10K Form
Sell
45
MREO
Mereo BioPharma Group PLC
Last Price:
3.74
Seasonality Move:
12.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MREO News And Ratings
See the #1 stock for the next 7 days that we like better than MREO
MREO Financial Statistics
Sales & Book Value
Annual Sales: | $10M |
---|---|
Cash Flow: | $-7.52M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.47 |
Price / Book: | 7.87 |
Profitability
EPS (TTM): | -0.30000 |
---|---|
Net Income (TTM): | $-45.32M |
Gross Margin: | $7.43M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Mereo BioPharma Group PLC Earnings Forecast
Key Mereo BioPharma Group PLC Financial Ratios
- The Gross Profit Margin over the past 7 years for MREO is 74.26%.
- The Selling, General & Administrative Expenses for MREO have been equal to 184.24% of Gross Profit Margin.
- The Research & Development expenses have been 174.18% of Revenue.
- The Interest Expense is -9.78% of Operating Income.
- The Net Earning history of MREO is -294.66% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 5 years.
Mereo BioPharma Group PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | MREO |
CUSIP: | 589492 |
Website: | mereobiopharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
MREO Technical Analysis vs Fundamental Analysis
Sell
45
Mereo BioPharma Group PLC (MREO)
is a Sell
Is Mereo BioPharma Group PLC a Buy or a Sell?
-
Mereo BioPharma Group PLC stock is rated a Sell
The current Mereo BioPharma Group PLC [MREO] share price is $3.68. The Score for MREO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.